nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Promazine—Tamoxifen—pancreatic cancer	0.498	1	CrCrCtD
Propericiazine—Pigmentation disorder—Sunitinib—pancreatic cancer	0.0102	0.0272	CcSEcCtD
Propericiazine—Priapism—Tamoxifen—pancreatic cancer	0.0082	0.022	CcSEcCtD
Propericiazine—Menstruation irregular—Tamoxifen—pancreatic cancer	0.00716	0.0192	CcSEcCtD
Propericiazine—Arrhythmia supraventricular—Gemcitabine—pancreatic cancer	0.00702	0.0188	CcSEcCtD
Propericiazine—Sudden death—Sunitinib—pancreatic cancer	0.00663	0.0178	CcSEcCtD
Propericiazine—Deep vein thrombosis—Tamoxifen—pancreatic cancer	0.00651	0.0174	CcSEcCtD
Propericiazine—Deep vein thrombosis—Erlotinib—pancreatic cancer	0.00644	0.0173	CcSEcCtD
Propericiazine—Parkinsonism—Fluorouracil—pancreatic cancer	0.00589	0.0158	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Epirubicin—pancreatic cancer	0.00574	0.0154	CcSEcCtD
Propericiazine—Deep vein thrombosis—Sunitinib—pancreatic cancer	0.00558	0.0149	CcSEcCtD
Propericiazine—Sudden death—Irinotecan—pancreatic cancer	0.00546	0.0146	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Doxorubicin—pancreatic cancer	0.00531	0.0142	CcSEcCtD
Propericiazine—Sudden death—Fluorouracil—pancreatic cancer	0.00523	0.014	CcSEcCtD
Propericiazine—Akathisia—Irinotecan—pancreatic cancer	0.00505	0.0135	CcSEcCtD
Propericiazine—Liver injury—Tamoxifen—pancreatic cancer	0.00471	0.0126	CcSEcCtD
Propericiazine—Amenorrhoea—Tamoxifen—pancreatic cancer	0.00451	0.0121	CcSEcCtD
Propericiazine—Venous thromboembolism—Epirubicin—pancreatic cancer	0.00444	0.0119	CcSEcCtD
Propericiazine—Venous thromboembolism—Doxorubicin—pancreatic cancer	0.0041	0.011	CcSEcCtD
Propericiazine—Pulmonary embolism—Tamoxifen—pancreatic cancer	0.00396	0.0106	CcSEcCtD
Propericiazine—Pigmentation disorder—Epirubicin—pancreatic cancer	0.00391	0.0105	CcSEcCtD
Propericiazine—Pigmentation disorder—Doxorubicin—pancreatic cancer	0.00361	0.00968	CcSEcCtD
Propericiazine—Menstruation irregular—Docetaxel—pancreatic cancer	0.00349	0.00935	CcSEcCtD
Propericiazine—Pulmonary embolism—Sunitinib—pancreatic cancer	0.00339	0.00909	CcSEcCtD
Propericiazine—Deep vein thrombosis—Docetaxel—pancreatic cancer	0.00318	0.00851	CcSEcCtD
Propericiazine—Pulmonary embolism—Irinotecan—pancreatic cancer	0.0028	0.00749	CcSEcCtD
Propericiazine—Nasal congestion—Sunitinib—pancreatic cancer	0.0027	0.00724	CcSEcCtD
Propericiazine—Hypokalaemia—Erlotinib—pancreatic cancer	0.00259	0.00694	CcSEcCtD
Propericiazine—Embolism venous—Epirubicin—pancreatic cancer	0.00258	0.00692	CcSEcCtD
Propericiazine—Embolism venous—Doxorubicin—pancreatic cancer	0.00239	0.0064	CcSEcCtD
Propericiazine—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00229	0.00613	CcSEcCtD
Propericiazine—Weight increased—Tamoxifen—pancreatic cancer	0.00226	0.00606	CcSEcCtD
Propericiazine—Hypokalaemia—Sunitinib—pancreatic cancer	0.00224	0.00601	CcSEcCtD
Propericiazine—Pneumonia—Tamoxifen—pancreatic cancer	0.00223	0.00597	CcSEcCtD
Propericiazine—Photosensitivity—Fluorouracil—pancreatic cancer	0.00221	0.00593	CcSEcCtD
Propericiazine—Pneumonia—Erlotinib—pancreatic cancer	0.00221	0.00591	CcSEcCtD
Propericiazine—Amenorrhoea—Docetaxel—pancreatic cancer	0.0022	0.00589	CcSEcCtD
Propericiazine—Pulmonary embolism—Docetaxel—pancreatic cancer	0.00193	0.00518	CcSEcCtD
Propericiazine—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00192	0.00514	CcSEcCtD
Propericiazine—Pneumonia—Sunitinib—pancreatic cancer	0.00191	0.00511	CcSEcCtD
Propericiazine—Hypokalaemia—Irinotecan—pancreatic cancer	0.00185	0.00495	CcSEcCtD
Propericiazine—Hypokalaemia—Gemcitabine—pancreatic cancer	0.0018	0.00482	CcSEcCtD
Propericiazine—Arrhythmia—Tamoxifen—pancreatic cancer	0.00178	0.00476	CcSEcCtD
Propericiazine—Arrhythmia—Erlotinib—pancreatic cancer	0.00176	0.00471	CcSEcCtD
Propericiazine—Sweating increased—Irinotecan—pancreatic cancer	0.00171	0.00458	CcSEcCtD
Propericiazine—Eosinophilia—Fluorouracil—pancreatic cancer	0.00166	0.00445	CcSEcCtD
Propericiazine—Angioedema—Tamoxifen—pancreatic cancer	0.00158	0.00424	CcSEcCtD
Propericiazine—Cardiac disorder—Sunitinib—pancreatic cancer	0.00158	0.00424	CcSEcCtD
Propericiazine—Pneumonia—Irinotecan—pancreatic cancer	0.00157	0.00421	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—pancreatic cancer	0.00155	0.00415	CcSEcCtD
Propericiazine—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00154	0.00413	CcSEcCtD
Propericiazine—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00153	0.00411	CcSEcCtD
Propericiazine—Pneumonia—Gemcitabine—pancreatic cancer	0.00153	0.0041	CcSEcCtD
Propericiazine—Jaundice—Irinotecan—pancreatic cancer	0.00152	0.00408	CcSEcCtD
Propericiazine—Arrhythmia—Sunitinib—pancreatic cancer	0.00152	0.00408	CcSEcCtD
Propericiazine—Pneumonia—Fluorouracil—pancreatic cancer	0.00151	0.00403	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00148	0.00397	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—pancreatic cancer	0.00148	0.00397	CcSEcCtD
Propericiazine—Dry mouth—Tamoxifen—pancreatic cancer	0.00144	0.00386	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—pancreatic cancer	0.00143	0.00384	CcSEcCtD
Propericiazine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00142	0.00381	CcSEcCtD
Propericiazine—Oedema—Tamoxifen—pancreatic cancer	0.00141	0.00379	CcSEcCtD
Propericiazine—Infection—Tamoxifen—pancreatic cancer	0.0014	0.00376	CcSEcCtD
Propericiazine—Oedema—Erlotinib—pancreatic cancer	0.0014	0.00375	CcSEcCtD
Propericiazine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.0014	0.00374	CcSEcCtD
Propericiazine—Infection—Erlotinib—pancreatic cancer	0.00139	0.00372	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—pancreatic cancer	0.00139	0.00371	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00137	0.00368	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—pancreatic cancer	0.00137	0.00368	CcSEcCtD
Propericiazine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00137	0.00366	CcSEcCtD
Propericiazine—Angioedema—Sunitinib—pancreatic cancer	0.00136	0.00363	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—pancreatic cancer	0.00134	0.0036	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.0013	0.00349	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—pancreatic cancer	0.0013	0.00349	CcSEcCtD
Propericiazine—Cardiac disorder—Irinotecan—pancreatic cancer	0.0013	0.00349	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—pancreatic cancer	0.00128	0.00344	CcSEcCtD
Propericiazine—Insomnia—Tamoxifen—pancreatic cancer	0.00128	0.00342	CcSEcCtD
Propericiazine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00127	0.0034	CcSEcCtD
Propericiazine—Insomnia—Erlotinib—pancreatic cancer	0.00127	0.00339	CcSEcCtD
Propericiazine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00126	0.00338	CcSEcCtD
Propericiazine—Arrhythmia—Irinotecan—pancreatic cancer	0.00125	0.00336	CcSEcCtD
Propericiazine—Dyspnoea—Erlotinib—pancreatic cancer	0.00125	0.00334	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00124	0.00333	CcSEcCtD
Propericiazine—Dry mouth—Sunitinib—pancreatic cancer	0.00124	0.00331	CcSEcCtD
Propericiazine—Arrhythmia—Gemcitabine—pancreatic cancer	0.00122	0.00327	CcSEcCtD
Propericiazine—Oedema—Sunitinib—pancreatic cancer	0.00121	0.00324	CcSEcCtD
Propericiazine—Constipation—Tamoxifen—pancreatic cancer	0.00121	0.00324	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.00121	0.00323	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—pancreatic cancer	0.00121	0.00323	CcSEcCtD
Propericiazine—Infection—Sunitinib—pancreatic cancer	0.0012	0.00322	CcSEcCtD
Propericiazine—Arrhythmia—Fluorouracil—pancreatic cancer	0.0012	0.00322	CcSEcCtD
Propericiazine—Constipation—Erlotinib—pancreatic cancer	0.0012	0.0032	CcSEcCtD
Propericiazine—Body temperature increased—Erlotinib—pancreatic cancer	0.00111	0.00296	CcSEcCtD
Propericiazine—Weight increased—Docetaxel—pancreatic cancer	0.0011	0.00296	CcSEcCtD
Propericiazine—Vision blurred—Fluorouracil—pancreatic cancer	0.0011	0.00295	CcSEcCtD
Propericiazine—Insomnia—Sunitinib—pancreatic cancer	0.0011	0.00293	CcSEcCtD
Propericiazine—Pneumonia—Docetaxel—pancreatic cancer	0.00109	0.00291	CcSEcCtD
Propericiazine—Dyspnoea—Sunitinib—pancreatic cancer	0.00108	0.00289	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—pancreatic cancer	0.00108	0.00289	CcSEcCtD
Propericiazine—Jaundice—Docetaxel—pancreatic cancer	0.00105	0.00282	CcSEcCtD
Propericiazine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00104	0.00279	CcSEcCtD
Propericiazine—Constipation—Sunitinib—pancreatic cancer	0.00104	0.00277	CcSEcCtD
Propericiazine—Agranulocytosis—Docetaxel—pancreatic cancer	0.00101	0.0027	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—pancreatic cancer	0.00101	0.0027	CcSEcCtD
Propericiazine—Confusional state—Irinotecan—pancreatic cancer	0.00101	0.00269	CcSEcCtD
Propericiazine—Oedema—Irinotecan—pancreatic cancer	0.000997	0.00267	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000997	0.00267	CcSEcCtD
Propericiazine—Infection—Irinotecan—pancreatic cancer	0.000991	0.00265	CcSEcCtD
Propericiazine—Oedema—Gemcitabine—pancreatic cancer	0.000972	0.0026	CcSEcCtD
Propericiazine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000967	0.00259	CcSEcCtD
Propericiazine—Infection—Gemcitabine—pancreatic cancer	0.000965	0.00259	CcSEcCtD
Propericiazine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000964	0.00258	CcSEcCtD
Propericiazine—Confusional state—Fluorouracil—pancreatic cancer	0.000963	0.00258	CcSEcCtD
Propericiazine—Body temperature increased—Sunitinib—pancreatic cancer	0.000957	0.00256	CcSEcCtD
Propericiazine—Diarrhoea—Erlotinib—pancreatic cancer	0.000957	0.00256	CcSEcCtD
Propericiazine—Oedema—Fluorouracil—pancreatic cancer	0.000955	0.00256	CcSEcCtD
Propericiazine—Infection—Fluorouracil—pancreatic cancer	0.000949	0.00254	CcSEcCtD
Propericiazine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000939	0.00252	CcSEcCtD
Propericiazine—Tachycardia—Fluorouracil—pancreatic cancer	0.000932	0.0025	CcSEcCtD
Propericiazine—Hypotension—Irinotecan—pancreatic cancer	0.000932	0.0025	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—pancreatic cancer	0.000932	0.0025	CcSEcCtD
Propericiazine—Hypotension—Gemcitabine—pancreatic cancer	0.000908	0.00243	CcSEcCtD
Propericiazine—Insomnia—Irinotecan—pancreatic cancer	0.000902	0.00242	CcSEcCtD
Propericiazine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000901	0.00241	CcSEcCtD
Propericiazine—Vomiting—Tamoxifen—pancreatic cancer	0.000899	0.00241	CcSEcCtD
Propericiazine—Hypotension—Fluorouracil—pancreatic cancer	0.000893	0.00239	CcSEcCtD
Propericiazine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000892	0.00239	CcSEcCtD
Propericiazine—Rash—Tamoxifen—pancreatic cancer	0.000891	0.00239	CcSEcCtD
Propericiazine—Dermatitis—Tamoxifen—pancreatic cancer	0.000891	0.00239	CcSEcCtD
Propericiazine—Vomiting—Erlotinib—pancreatic cancer	0.000889	0.00238	CcSEcCtD
Propericiazine—Dyspnoea—Irinotecan—pancreatic cancer	0.000889	0.00238	CcSEcCtD
Propericiazine—Somnolence—Irinotecan—pancreatic cancer	0.000887	0.00237	CcSEcCtD
Propericiazine—Rash—Erlotinib—pancreatic cancer	0.000882	0.00236	CcSEcCtD
Propericiazine—Dermatitis—Erlotinib—pancreatic cancer	0.000881	0.00236	CcSEcCtD
Propericiazine—Insomnia—Gemcitabine—pancreatic cancer	0.000879	0.00235	CcSEcCtD
Propericiazine—Arrhythmia—Docetaxel—pancreatic cancer	0.000867	0.00232	CcSEcCtD
Propericiazine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000866	0.00232	CcSEcCtD
Propericiazine—Insomnia—Fluorouracil—pancreatic cancer	0.000864	0.00231	CcSEcCtD
Propericiazine—Somnolence—Gemcitabine—pancreatic cancer	0.000864	0.00231	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—pancreatic cancer	0.000861	0.00231	CcSEcCtD
Propericiazine—Constipation—Irinotecan—pancreatic cancer	0.000853	0.00228	CcSEcCtD
Propericiazine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000852	0.00228	CcSEcCtD
Propericiazine—Somnolence—Fluorouracil—pancreatic cancer	0.000849	0.00227	CcSEcCtD
Propericiazine—Nausea—Tamoxifen—pancreatic cancer	0.00084	0.00225	CcSEcCtD
Propericiazine—Constipation—Gemcitabine—pancreatic cancer	0.000831	0.00223	CcSEcCtD
Propericiazine—Nausea—Erlotinib—pancreatic cancer	0.000831	0.00223	CcSEcCtD
Propericiazine—Diarrhoea—Sunitinib—pancreatic cancer	0.000829	0.00222	CcSEcCtD
Propericiazine—Asthma—Epirubicin—pancreatic cancer	0.000818	0.00219	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—pancreatic cancer	0.00081	0.00217	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000797	0.00213	CcSEcCtD
Propericiazine—Body temperature increased—Irinotecan—pancreatic cancer	0.000788	0.00211	CcSEcCtD
Propericiazine—Vomiting—Sunitinib—pancreatic cancer	0.00077	0.00206	CcSEcCtD
Propericiazine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000768	0.00206	CcSEcCtD
Propericiazine—Rash—Sunitinib—pancreatic cancer	0.000763	0.00204	CcSEcCtD
Propericiazine—Dermatitis—Sunitinib—pancreatic cancer	0.000763	0.00204	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—pancreatic cancer	0.000757	0.00203	CcSEcCtD
Propericiazine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000755	0.00202	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000749	0.00201	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000746	0.002	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—pancreatic cancer	0.000744	0.00199	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000738	0.00198	CcSEcCtD
Propericiazine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000735	0.00197	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—pancreatic cancer	0.000733	0.00196	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—pancreatic cancer	0.000729	0.00195	CcSEcCtD
Propericiazine—Nausea—Sunitinib—pancreatic cancer	0.000719	0.00193	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—pancreatic cancer	0.000711	0.0019	CcSEcCtD
Propericiazine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000704	0.00189	CcSEcCtD
Propericiazine—Dry mouth—Docetaxel—pancreatic cancer	0.000703	0.00188	CcSEcCtD
Propericiazine—Confusional state—Docetaxel—pancreatic cancer	0.000695	0.00186	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000691	0.00185	CcSEcCtD
Propericiazine—Oedema—Docetaxel—pancreatic cancer	0.00069	0.00185	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—pancreatic cancer	0.000689	0.00184	CcSEcCtD
Propericiazine—Infection—Docetaxel—pancreatic cancer	0.000685	0.00183	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000683	0.00183	CcSEcCtD
Propericiazine—Diarrhoea—Irinotecan—pancreatic cancer	0.000682	0.00183	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—pancreatic cancer	0.00068	0.00182	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—pancreatic cancer	0.000679	0.00182	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000675	0.00181	CcSEcCtD
Propericiazine—Tachycardia—Docetaxel—pancreatic cancer	0.000673	0.0018	CcSEcCtD
Propericiazine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000665	0.00178	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—pancreatic cancer	0.000658	0.00176	CcSEcCtD
Propericiazine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000654	0.00175	CcSEcCtD
Propericiazine—Hypotension—Docetaxel—pancreatic cancer	0.000644	0.00173	CcSEcCtD
Propericiazine—Vomiting—Irinotecan—pancreatic cancer	0.000634	0.0017	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00063	0.00169	CcSEcCtD
Propericiazine—Rash—Irinotecan—pancreatic cancer	0.000629	0.00168	CcSEcCtD
Propericiazine—Dermatitis—Irinotecan—pancreatic cancer	0.000628	0.00168	CcSEcCtD
Propericiazine—Insomnia—Docetaxel—pancreatic cancer	0.000624	0.00167	CcSEcCtD
Propericiazine—Vomiting—Gemcitabine—pancreatic cancer	0.000618	0.00165	CcSEcCtD
Propericiazine—Dyspnoea—Docetaxel—pancreatic cancer	0.000615	0.00165	CcSEcCtD
Propericiazine—Somnolence—Docetaxel—pancreatic cancer	0.000613	0.00164	CcSEcCtD
Propericiazine—Rash—Gemcitabine—pancreatic cancer	0.000613	0.00164	CcSEcCtD
Propericiazine—Dermatitis—Gemcitabine—pancreatic cancer	0.000612	0.00164	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000608	0.00163	CcSEcCtD
Propericiazine—Vomiting—Fluorouracil—pancreatic cancer	0.000607	0.00163	CcSEcCtD
Propericiazine—Rash—Fluorouracil—pancreatic cancer	0.000602	0.00161	CcSEcCtD
Propericiazine—Dermatitis—Fluorouracil—pancreatic cancer	0.000602	0.00161	CcSEcCtD
Propericiazine—Nausea—Irinotecan—pancreatic cancer	0.000592	0.00159	CcSEcCtD
Propericiazine—Constipation—Docetaxel—pancreatic cancer	0.00059	0.00158	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—pancreatic cancer	0.000585	0.00157	CcSEcCtD
Propericiazine—Nausea—Gemcitabine—pancreatic cancer	0.000577	0.00155	CcSEcCtD
Propericiazine—Nausea—Fluorouracil—pancreatic cancer	0.000567	0.00152	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000562	0.00151	CcSEcCtD
Propericiazine—Body temperature increased—Docetaxel—pancreatic cancer	0.000545	0.00146	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000541	0.00145	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—pancreatic cancer	0.000537	0.00144	CcSEcCtD
Propericiazine—Agitation—Epirubicin—pancreatic cancer	0.000524	0.0014	CcSEcCtD
Propericiazine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000508	0.00136	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—pancreatic cancer	0.000497	0.00133	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—pancreatic cancer	0.000485	0.0013	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—pancreatic cancer	0.000474	0.00127	CcSEcCtD
Propericiazine—Diarrhoea—Docetaxel—pancreatic cancer	0.000472	0.00126	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—pancreatic cancer	0.000469	0.00126	CcSEcCtD
Propericiazine—Oedema—Epirubicin—pancreatic cancer	0.000465	0.00125	CcSEcCtD
Propericiazine—Infection—Epirubicin—pancreatic cancer	0.000462	0.00124	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—pancreatic cancer	0.000454	0.00122	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00045	0.0012	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—pancreatic cancer	0.000439	0.00118	CcSEcCtD
Propericiazine—Vomiting—Docetaxel—pancreatic cancer	0.000438	0.00117	CcSEcCtD
Propericiazine—Rash—Docetaxel—pancreatic cancer	0.000435	0.00116	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—pancreatic cancer	0.000435	0.00116	CcSEcCtD
Propericiazine—Dermatitis—Docetaxel—pancreatic cancer	0.000434	0.00116	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—pancreatic cancer	0.000434	0.00116	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—pancreatic cancer	0.00043	0.00115	CcSEcCtD
Propericiazine—Infection—Doxorubicin—pancreatic cancer	0.000428	0.00114	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—pancreatic cancer	0.000421	0.00113	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—pancreatic cancer	0.00042	0.00112	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000416	0.00111	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—pancreatic cancer	0.000415	0.00111	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—pancreatic cancer	0.000413	0.00111	CcSEcCtD
Propericiazine—Nausea—Docetaxel—pancreatic cancer	0.00041	0.0011	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—pancreatic cancer	0.000402	0.00108	CcSEcCtD
Propericiazine—Constipation—Epirubicin—pancreatic cancer	0.000398	0.00107	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—pancreatic cancer	0.000389	0.00104	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000384	0.00103	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—pancreatic cancer	0.000383	0.00102	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—pancreatic cancer	0.000368	0.000986	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—pancreatic cancer	0.000368	0.000985	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000343	0.000918	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00034	0.000911	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—pancreatic cancer	0.000318	0.000852	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000317	0.000849	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—pancreatic cancer	0.000296	0.000792	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000294	0.000789	CcSEcCtD
Propericiazine—Rash—Epirubicin—pancreatic cancer	0.000293	0.000785	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—pancreatic cancer	0.000293	0.000785	CcSEcCtD
Propericiazine—Nausea—Epirubicin—pancreatic cancer	0.000276	0.00074	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—pancreatic cancer	0.000274	0.000733	CcSEcCtD
Propericiazine—Rash—Doxorubicin—pancreatic cancer	0.000271	0.000727	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—pancreatic cancer	0.000271	0.000726	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—pancreatic cancer	0.000256	0.000685	CcSEcCtD
Propericiazine—ADRA2A—Signaling Pathways—PPY—pancreatic cancer	0.00011	0.000856	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MEN1—pancreatic cancer	0.00011	0.000856	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GAST—pancreatic cancer	0.000109	0.000846	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SSTR2—pancreatic cancer	0.000108	0.00084	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PLAU—pancreatic cancer	0.000108	0.000839	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000108	0.000838	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AGTR1—pancreatic cancer	0.000107	0.000834	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CNR1—pancreatic cancer	0.000106	0.000823	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SHH—pancreatic cancer	0.000105	0.000816	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCKBR—pancreatic cancer	0.000104	0.000812	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000104	0.000811	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—SST—pancreatic cancer	0.000104	0.00081	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000104	0.000807	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IAPP—pancreatic cancer	0.000104	0.000806	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SCT—pancreatic cancer	0.000103	0.000802	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HEY1—pancreatic cancer	0.000103	0.000802	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.000102	0.000795	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GCG—pancreatic cancer	0.000102	0.000795	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	9.98e-05	0.000775	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTHLH—pancreatic cancer	9.96e-05	0.000774	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTCH1—pancreatic cancer	9.96e-05	0.000774	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCK—pancreatic cancer	9.84e-05	0.000765	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DTX4—pancreatic cancer	9.82e-05	0.000763	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GLI1—pancreatic cancer	9.82e-05	0.000763	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AGTR1—pancreatic cancer	9.76e-05	0.000758	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CNR1—pancreatic cancer	9.62e-05	0.000747	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CG—pancreatic cancer	9.61e-05	0.000747	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CNR2—pancreatic cancer	9.59e-05	0.000745	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GLP1R—pancreatic cancer	9.59e-05	0.000745	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CXCL8—pancreatic cancer	9.59e-05	0.000745	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PPP2R5B—pancreatic cancer	9.55e-05	0.000742	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NRP1—pancreatic cancer	9.55e-05	0.000742	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—EGF—pancreatic cancer	9.5e-05	0.000738	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GLP1R—pancreatic cancer	9.47e-05	0.000736	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCKAR—pancreatic cancer	9.44e-05	0.000733	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—DPYD—pancreatic cancer	9.31e-05	0.000724	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GCG—pancreatic cancer	9.29e-05	0.000722	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HEY2—pancreatic cancer	9.2e-05	0.000715	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JAG2—pancreatic cancer	9.15e-05	0.000711	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SST—pancreatic cancer	9.11e-05	0.000708	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MEN1—pancreatic cancer	9.02e-05	0.000701	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.98e-05	0.000698	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GAST—pancreatic cancer	8.98e-05	0.000698	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—JAG1—pancreatic cancer	8.91e-05	0.000693	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH3—pancreatic cancer	8.88e-05	0.00069	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGTR1—pancreatic cancer	8.86e-05	0.000689	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—SLC2A2—pancreatic cancer	8.84e-05	0.000687	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	8.71e-05	0.000677	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SHH—pancreatic cancer	8.6e-05	0.000668	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH4—pancreatic cancer	8.55e-05	0.000664	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SCT—pancreatic cancer	8.51e-05	0.000662	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HEY1—pancreatic cancer	8.51e-05	0.000662	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IAPP—pancreatic cancer	8.5e-05	0.00066	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CD—pancreatic cancer	8.45e-05	0.000656	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CNR1—pancreatic cancer	8.41e-05	0.000653	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	8.16e-05	0.000634	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTHLH—pancreatic cancer	8.16e-05	0.000634	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTCH1—pancreatic cancer	8.16e-05	0.000634	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCK—pancreatic cancer	8.12e-05	0.000631	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GCG—pancreatic cancer	8.12e-05	0.000631	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CNR2—pancreatic cancer	7.92e-05	0.000615	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GLP1R—pancreatic cancer	7.92e-05	0.000615	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CXCL8—pancreatic cancer	7.91e-05	0.000615	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.9e-05	0.000614	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCKAR—pancreatic cancer	7.79e-05	0.000605	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGTR1—pancreatic cancer	7.74e-05	0.000602	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STK11—pancreatic cancer	7.63e-05	0.000593	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JAG2—pancreatic cancer	7.55e-05	0.000587	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SST—pancreatic cancer	7.46e-05	0.00058	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MEN1—pancreatic cancer	7.44e-05	0.000578	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CB—pancreatic cancer	7.36e-05	0.000572	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	7.36e-05	0.000572	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JAG1—pancreatic cancer	7.3e-05	0.000567	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH3—pancreatic cancer	7.27e-05	0.000565	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	7.17e-05	0.000557	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	7.11e-05	0.000553	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SHH—pancreatic cancer	7.1e-05	0.000552	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH4—pancreatic cancer	7.06e-05	0.000548	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IAPP—pancreatic cancer	7.01e-05	0.000545	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CNR1—pancreatic cancer	6.88e-05	0.000535	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.88e-05	0.000535	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CD44—pancreatic cancer	6.84e-05	0.000532	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTHLH—pancreatic cancer	6.73e-05	0.000523	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTCH1—pancreatic cancer	6.73e-05	0.000523	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SMAD4—pancreatic cancer	6.69e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CG—pancreatic cancer	6.68e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GCG—pancreatic cancer	6.65e-05	0.000517	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	6.61e-05	0.000514	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GCG—pancreatic cancer	6.56e-05	0.00051	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HES1—pancreatic cancer	6.53e-05	0.000507	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	6.47e-05	0.000503	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGTR1—pancreatic cancer	6.34e-05	0.000493	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.25e-05	0.000486	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STK11—pancreatic cancer	6.25e-05	0.000486	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—STK11—pancreatic cancer	6.17e-05	0.000479	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SST—pancreatic cancer	6.16e-05	0.000478	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.07e-05	0.000472	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	6.02e-05	0.000468	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL8—pancreatic cancer	6.01e-05	0.000467	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	6e-05	0.000466	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SRC—pancreatic cancer	5.9e-05	0.000458	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CD—pancreatic cancer	5.87e-05	0.000456	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	5.75e-05	0.000446	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TERT—pancreatic cancer	5.72e-05	0.000444	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	5.68e-05	0.000441	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NRAS—pancreatic cancer	5.68e-05	0.000441	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.64e-05	0.000438	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	5.51e-05	0.000428	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	5.49e-05	0.000426	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SMAD4—pancreatic cancer	5.47e-05	0.000425	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HIF1A—pancreatic cancer	5.47e-05	0.000425	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TSC2—pancreatic cancer	5.46e-05	0.000424	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL8—pancreatic cancer	5.42e-05	0.000421	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HES1—pancreatic cancer	5.35e-05	0.000415	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOE—pancreatic cancer	5.34e-05	0.000415	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.34e-05	0.000415	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TYMS—pancreatic cancer	5.31e-05	0.000412	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	5.27e-05	0.00041	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	5.23e-05	0.000407	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KDR—pancreatic cancer	5.23e-05	0.000407	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	5.16e-05	0.000401	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CB—pancreatic cancer	5.12e-05	0.000398	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFKBIA—pancreatic cancer	4.98e-05	0.000387	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH1—pancreatic cancer	4.93e-05	0.000383	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—pancreatic cancer	4.92e-05	0.000382	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—KRAS—pancreatic cancer	4.88e-05	0.00038	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	4.85e-05	0.000377	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CG—pancreatic cancer	4.82e-05	0.000374	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—NRAS—pancreatic cancer	4.82e-05	0.000374	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGF—pancreatic cancer	4.76e-05	0.00037	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TERT—pancreatic cancer	4.68e-05	0.000364	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.65e-05	0.000362	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	4.52e-05	0.000351	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	4.49e-05	0.000349	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HIF1A—pancreatic cancer	4.48e-05	0.000348	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	4.47e-05	0.000347	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TSC2—pancreatic cancer	4.47e-05	0.000347	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	4.41e-05	0.000343	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—pancreatic cancer	4.39e-05	0.000341	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOE—pancreatic cancer	4.37e-05	0.00034	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—pancreatic cancer	4.34e-05	0.000337	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOE—pancreatic cancer	4.32e-05	0.000335	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KDR—pancreatic cancer	4.28e-05	0.000333	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CD—pancreatic cancer	4.24e-05	0.000329	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	4.22e-05	0.000328	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.2e-05	0.000326	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—HRAS—pancreatic cancer	4.15e-05	0.000323	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—KRAS—pancreatic cancer	4.15e-05	0.000322	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	4.07e-05	0.000317	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	4.06e-05	0.000315	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	4.04e-05	0.000314	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	3.95e-05	0.000307	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	3.95e-05	0.000307	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	3.9e-05	0.000303	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	3.9e-05	0.000303	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	3.87e-05	0.0003	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.81e-05	0.000296	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARG—pancreatic cancer	3.76e-05	0.000292	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	3.7e-05	0.000287	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CB—pancreatic cancer	3.69e-05	0.000287	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	3.69e-05	0.000287	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—pancreatic cancer	3.67e-05	0.000285	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	3.61e-05	0.00028	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	3.6e-05	0.000279	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—pancreatic cancer	3.55e-05	0.000276	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	3.54e-05	0.000275	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HRAS—pancreatic cancer	3.53e-05	0.000274	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	3.47e-05	0.00027	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.44e-05	0.000267	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—pancreatic cancer	3.43e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	3.42e-05	0.000266	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	3.4e-05	0.000264	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—pancreatic cancer	3.4e-05	0.000264	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	3.36e-05	0.000261	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	3.33e-05	0.000259	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCND1—pancreatic cancer	3.31e-05	0.000257	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CTNNB1—pancreatic cancer	3.27e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	3.26e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	3.26e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	3.22e-05	0.00025	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—pancreatic cancer	3.21e-05	0.000249	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTEN—pancreatic cancer	3.19e-05	0.000248	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	3.12e-05	0.000242	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—pancreatic cancer	3.11e-05	0.000242	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	3.02e-05	0.000235	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	2.98e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	2.97e-05	0.000231	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SRC—pancreatic cancer	2.96e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	2.96e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	2.91e-05	0.000226	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	2.89e-05	0.000224	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—pancreatic cancer	2.88e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	2.86e-05	0.000222	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—pancreatic cancer	2.85e-05	0.000222	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NRAS—pancreatic cancer	2.85e-05	0.000221	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.84e-05	0.00022	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	2.81e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	2.8e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	2.78e-05	0.000216	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	2.71e-05	0.00021	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	2.68e-05	0.000208	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MYC—pancreatic cancer	2.65e-05	0.000206	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	2.65e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	2.63e-05	0.000204	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	2.61e-05	0.000203	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	2.59e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTEN—pancreatic cancer	2.58e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.58e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	2.55e-05	0.000198	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	2.5e-05	0.000194	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	2.45e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	2.42e-05	0.000188	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	2.4e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	2.38e-05	0.000185	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	2.36e-05	0.000183	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	2.34e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	2.33e-05	0.000181	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	2.32e-05	0.00018	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	2.3e-05	0.000178	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	2.25e-05	0.000175	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	2.23e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	2.21e-05	0.000172	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—pancreatic cancer	2.18e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	2.17e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	2.17e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	2.17e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	2.16e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	2.12e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	2.1e-05	0.000163	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	2.08e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	2.01e-05	0.000156	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	2e-05	0.000155	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.95e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	1.93e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	1.92e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.84e-05	0.000143	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	1.84e-05	0.000143	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	1.82e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	1.79e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.79e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	1.78e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	1.75e-05	0.000136	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	1.71e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	1.66e-05	0.000129	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.52e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	1.51e-05	0.000117	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—pancreatic cancer	1.49e-05	0.000115	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	1.47e-05	0.000114	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	1.41e-05	0.000109	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	1.24e-05	9.66e-05	CbGpPWpGaD
